July 12, 2022 Comments Off on New patent for Novartis drug MAYZENT Posted in: Patent Added Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
July 12, 2022 Comments Off on New patent for Acacia drug BARHEMSYS Posted in: Patent Added Annual Drug Patent Expirations for BARHEMSYS Barhemsys is a drug marketed by Acacia and is included in one NDA. There are four patents protecting this drug. This drug has thirty-eight…
The post New patent for Acacia drug BARHEMSYS appeared first on Dru…
